VWM
WST icon

Venturi Wealth Management’s West Pharmaceutical WST Stock Holding History

Venturi Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
3,130
+357
+13% +$109K 0.04% 207
2026
Q1 		$695K Buy
2,773
+227
+9% +$56.5K 0.03% 270
2025
Q4 		$700K Sell
2,546
-178
-7% -$48.7K 0.03% 258
2025
Q3 		$715K Sell
2,724
-696
-20% -$169K 0.03% 259
2025
Q2 		$748K Buy
3,420
+215
+7% +$46K 0.04% 247
2025
Q1 		$718K Buy
3,205
+334
+12% +$92.1K 0.04% 261
2024
Q4 		$940K Sell
2,871
-221
-7% -$69.5K 0.05% 215
2024
Q3 		$928K Buy
3,092
+368
+14% +$113K 0.05% 204
2024
Q2 		$897K Sell
2,724
-135
-5% -$47.7K 0.05% 197
2024
Q1 		$1.13M Sell
2,859
-55
-2% -$20.3K 0.07% 166
2023
Q4 		$1.03M Sell
2,914
-212
-7% -$75K 0.07% 163
2023
Q3 		$1.17M Sell
3,126
-185
-6% -$71.5K 0.09% 133
2023
Q2 		$1.27M Sell
3,311
-275
-8% -$98.2K 0.1% 114
2023
Q1 		$1.24M Sell
3,586
-255
-7% -$74.5K 0.1% 121
2022
Q4 		$904K Buy
3,841
+1,030
+37% +$244K 0.08% 178
2022
Q3 		$692K Buy
2,811
+356
+15% +$108K 0.07% 195
2022
Q2 		$742K Buy
2,455
+44
+2% +$14.3K 0.07% 180
2022
Q1 		$990K Buy
2,411
+62
+3% +$24.3K 0.08% 162
2021
Q4 		$1.1M Sell
2,349
-73
-3% -$31.4K 0.08% 152
2021
Q3 		$1.03M Sell
2,422
-393
-14% -$166K 0.09% 156
2021
Q2 		$1.01M Sell
2,815
-815
-22% -$269K 0.09% 151
2021
Q1 		$1.02M Sell
3,630
-113
-3% -$32.3K 0.1% 151
2020
Q4 		$1.06M Sell
3,743
-35
-0.9% -$9.82K 0.11% 139
2020
Q3 		$1.04M Buy
3,778
+1,244
+49% +$329K 0.12% 125
2020
Q2 		$576K Buy
+2,534
New +$498K 0.08% 173

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Venturi Wealth Management's WST Position: Q2 2026 in Review

Venturi Wealth Management increased its West Pharmaceutical (WST) stake by 13% in Q2 2026, buying an estimated $109K and bringing the position to 3,130 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #207.

Venturi Wealth Management first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.27M in Q2 2023. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Venturi Wealth Management held 3,130 shares of West Pharmaceutical worth $1.12M as of Q2 2026.
  • Venturi Wealth Management bought 357 West Pharmaceutical shares in Q2 2026, an estimated $109K.
  • West Pharmaceutical made up 0.04% of Venturi Wealth Management's portfolio in Q2 2026, its #207 holding.
  • Venturi Wealth Management first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Venturi Wealth Management's West Pharmaceutical position peaked at $1.27M in Q2 2023.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.